Pharmafile Logo
Pharmafocus logo
Advanced Search

Novo Nordisk

Showing 15 posts of 188 posts found.

andrew_ajello_-large

Novo Nordisk creates four senior vice presidents

February 1, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novo Nordisk

Novo Nordisk has promoted four corporate vice presidents within its ranks into senior vice presidents.  The following members of the US …

Appointment
Novo Nordisk image

EU approval for Novo Nordisk diabetes drugs

January 24, 2013
Sales and Marketing Novo Nordisk, Ryzodeg, Tresiba

Novo Nordisk is celebrating after European regulators approved two of its drugs for the treatment of adults with diabetes. The …

News

Novo Nordisk appoints Curtis Oltmans to US executive team

January 8, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, Oltmans

Novo Nordisk has announced that Curtis Oltmans has been promoted to corporate vice president and general counsel, Legal and Quality …

Appointment
Novo Nordisk image

European green light for Novo’s Tresiba

October 24, 2012
Sales and Marketing EMA, Novo Nordisk, Tresiba

The European Medicines Agency has given the go-ahead for Novo Nordisk’s Tresiba, a new basal analogue insulin to treat diabetes …

News
Novo Nordisk image

Novo Nordisk to expand Beijing R&D centre

September 25, 2012
Research and Development, Sales and Marketing Beijing, China, Novo Nordisk, R&D

Novo Nordisk is investing $100 million into enlarging its R&D facilities in Beijing into a state-of-the-art centre. Located in the …

News
Novo Nordisk image

BMJ: diabetes post-marketing studies used to boost sales

June 14, 2012
Sales and Marketing BMJ, Edwin Gale, Novo Nordisk, post-marketing

The use of post-marketing studies for diabetes is being used to sell more medicines rather than for science, according to …

News
sanofi website

Positive data for Sanofi’s diabetes drug

June 13, 2012
Research and Development, Sales and Marketing Lyxumia, Novo Nordisk, Sanofi, Victoza, diabetes

Sanofi’s new diabetes treatment Lyxumia has significantly reduced glycated hemoglobin (HbA1c) in two late-stage trials, the manufacturer says. Paris-based Sanofi …

News

Novo Nordisk appoints ex-Pfizer head

May 10, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, Pfizer, Robert Clark, regulatory affairs

Robert Clark will be joining Novo Nordisk as vice president, regulatory affairs. Clark will lead Novo Nordisk’s US regulatory team, …

Appointment
Novo Nordisk HQ

Victoza superiority to Januvia made official by FDA

April 10, 2012
Medical Communications, Sales and Marketing Januvia, Merck, Novo Nordisk, Victoza, diabetes

Novo Nordisk is now able to claim superiority for its diabetes drug Victoza compared to Merck’s rival treatment Januvia.The US …

News
Novo Nordisk image

Diabetes – the battle for control

February 15, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Novo Nordisk, Sanofi, Victoza, degludec, diabetes

This year marks the 90th anniversary of the first ever successful use of insulin to treat patients with type I …

Feature

Study supports GLP-1 agonists for weight loss

January 10, 2012
Research and Development, Sales and Marketing GLP-1, Novo Nordisk, Sanofi, diabetes, lilly

An independent study by academics has concluded that GLP-1 agonist drugs help patients to lose weight – with the effect …

News

AstraZeneca, Novo and Enlight sign collaborative research deal

December 20, 2011
Research and Development, Sales and Marketing AstraZeneca, Enlight, Novo Nordisk

AstraZeneca and Novo Nordisk have linked up with a US biosciences firm in a bid to enhance their R&D operations. …

News

Novo confident on ultra-long acting insulin

December 8, 2011
Sales and Marketing Novo Nordisk, diabetes, insulin

Novo Nordisk says a new combination of a long-acting insulin with a short-acting insulin helps patients maintain better control of …

News
MediKidz' haemophilia comic

Novo Nordisk sponsors haemophilia comic

October 7, 2011
Medical Communications Novo Nordisk, haemophilia, medical communications news

Novo Nordisk is sponsoring an educational comic about haemophilia for young sufferers of the blood disorder in the UK. It …

News

Fresh scrutiny for new diabetes drugs

September 15, 2011
Sales and Marketing Byetta, GLP-1, Januvia, Merck, Novo Nordisk, Victoza, diabetes

Merck’s Januvia and Lilly’s Byetta face renewed safety questions this week as the European Association for the Study of Diabetes …

News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026